David Schwartz, Ripple’s Chief Technology Officer has hit back at Charles Hoskinson over his defense of the Securities and Exchange Commission’s (SEC) comments on...
Intro Relmada Therapeutics (NASDAQ:RLMD) is advancing its NMDA antagonist, REL-1017 (esmethadone), as a novel antidepressant for the treatment of major depressive disorder (MDD). After...
By Christian Moess Laursen Ashmore Group said its assets under management fell in the first quarter of fiscal 2024, reflecting continuing institutional risk aversion....
Bitcoin mining operations in the United States, owned by Chinese entities, are currently under investigation for potential issues that could threaten national security, according...